BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2012
View Archived Issues
Takeda Pharmaceutical offers overview of third quarter fiscal 2011
Read More
BiondVax's phase II flu vaccine trial meets primary safety endpoint
Read More
Debiopharm commences phase Ib expansion study of Debio-0932
Read More
Hanmi and AngioLab enter licensing agreement
Read More
Studies point to benefit of sonothrombolysis after stroke
Read More
New antiviral agents disclosed by Alla Chem
Read More
Alla Chem presents new androgen receptor antagonists
Read More
Latvian company patents novel agents for influenza
Read More
New protein kinase inhibitors synthesized by Chinese team
Read More
Trials indicate ipilimumab can be administered with cancer vaccines
Read More
Novel tissue engineering scaffolds tested in vivo
Read More
Hyundai Pharmaceutical discloses new GPR119 receptor agonists
Read More
Novartis to revise product information for Rasilez in the E.U.
Read More
GlaxoSmithKline provides regulatory update on Tykerb/Tyverb
Read More
NeuroPhage Pharmaceuticals receives funding from Michael J. Fox Foundation
Read More
GlaxoSmithKline receives CHMP opinion on Nimenrix
Read More
Collaborating Japanese universities identify new potential target for cancer therapy
Read More
Gilead Sciences reports on ELECTRON trial
Read More
New approval for Zelboraf
Read More
Dainippon Sumitomo seeks line extension for Amlodin in Japan
Read More
EMA committee recommends conditional approval of Pixuvri
Read More
TCG Lifesciences chooses preclinical development candidate
Read More
CHMP recommends approval of Byetta line extension
Read More
FDA approves first medical therapy for endogenous Cushing's syndrome
Read More